The Highly Dynamic Nature Of Diuretic Response In Acute Heart Failure: Insights From The FASTR Trial

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Boehringer Ingelheim, Bristol Myers Squibb, Reprieve inc., Sequana Medical, Abbott, Merck</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Boehringer Ingelheim, Bristol Myers Squibb, Cardionomic, MagentaMed, Reprieve inc., FIRE1, Sequana Medical, Merck, Windtree Therapeutics, Precardia, Regeneron, BD, Edwards life sciences, and Lilly.</li><li>Equity/Stock(s)/Options - Reprieve inc, Sequana medical</li></ul>